North American Pharmacist Licensure Examination (NAPLEX) guideStudy & preparation

NAPLEX Compounding: How to Sort Preparation and Safety Questions

A practical method for NAPLEX compounding questions: identify the preparation, separate quantity and quality problems, and check the scope of the source before choosing an answer.

Short answer

Approach NAPLEX compounding questions by identifying the preparation and the specific quantity, scope, or quality issue being asked about. NABP's outline lists nonsterile and sterile compounding separately and includes compounding quantities within pharmaceutical calculations. A correct quantity calculation does not establish contamination control, and an FDA-approved ingredient does not make the resulting compounded product FDA-approved.

What kinds of compounding questions are in the NAPLEX outline?

Approach NAPLEX compounding questions by separating preparation type, standard scope, and the specific quantity or quality issue being asked about. NABP's content outline separately lists nonsterile and sterile compounding under 1.B and compounding quantities under 1.C.6. That distinction gives you a useful first question: does this item ask what preparation is involved, which requirements apply, or how much ingredient is needed?

The outline used here is effective May 1, 2025, checked November 3, 2026. Compounding sits within Foundational Knowledge for Pharmacy Practice. That whole domain has a 25% weight; the outline does not establish a separate compounding percentage. Do not turn the domain's weight into a promised number of compounding questions.

Use this sequence during study:

  1. Name the decision the question requests.
  2. Identify what the stem actually says about the preparation.
  3. Separate a quantity calculation from a scope or quality question.
  4. Select the relevant source and identify any information still missing.
  5. Explain why a tempting answer goes beyond the evidence given.

This is Passy's study method, not an NABP-required algorithm. Keep the full NAPLEX blueprint and domain guide beside your notes so focused compounding review remains part of a broader plan.

How do sterile and nonsterile preparation questions differ?

NABP lists the two preparation types separately. Start by recording which type the question states, then identify what it asks you to evaluate. A preparation label alone is not a complete answer to a question about quantities, scope, or quality.

For each practice item, write two short lines: “The preparation is described as…” and “The decision requested is…” If the stem does not establish the preparation type, note the missing information instead of filling the gap from a familiar-looking word.

Hazardous-drug handling can overlap with sterile preparation. USP's sterile-compounding FAQ says sterile hazardous-drug compounding also involves chapter <800>. Therefore, do not build three mutually exclusive study boxes labeled “sterile,” “nonsterile,” and “hazardous.” A sterile preparation can also raise hazardous-handling requirements.

For example, a fictional study prompt identifies a sterile hazardous preparation. The useful follow-up is to identify the overlapping standards, not to choose whether the preparation is “sterile or hazardous.” This example teaches classification; it does not specify a preparation procedure.

Once you can explain those distinctions, return to mixed practice. For broader review, 825 questions across five content domains are planned for launch in full NAPLEX prep.

How does a compounded drug differ from an approved generic?

FDA states that compounded drugs are not FDA-approved. Its compounding FAQ distinguishes them from approved generic drugs: FDA does not pre-approve a compounded product's quality, safety, or effectiveness.

Compounding can address patient needs that a suitable approved product does not meet. That purpose does not make every requested formulation appropriate or establish that a particular compounded product has FDA approval.

Consider this original reasoning exercise:

Claim: “The starting drug product is FDA-approved, so the final compounded preparation must also be FDA-approved.”

Answer: The conclusion does not follow. The starting product's approval is not approval of the resulting compounded preparation. To answer the question, keep the identity of the approved product separate from the identity of what was compounded.

A second overreach would be to conclude that all compounding is unsafe because compounded products lack FDA approval. FDA describes both a role for compounding and quality risks. Preserve both parts of that distinction in your notes.

The next step is to underline exactly which product an answer choice describes. If the question instead asks about an order or substitution decision, use the separate NAPLEX medication-use process guide to practice that source-selection task.

When should you check the scope of a compounding standard?

Check scope when the question turns on whether the stated activity falls within a standard. USP's chapter <797> FAQ distinguishes sterile compounding from administration and from qualifying preparation according to a manufacturer's approved labeling. Those distinctions have conditions; a single word such as “reconstitution” does not establish that an activity is outside the chapter's scope.

Use this fictional prompt: “A preparation involves reconstitution. Is that enough information to decide whether it is outside the sterile-compounding chapter?”

No. Your study answer should identify what still needs checking: the exact activity, the relevant manufacturer's approved labeling, and the chapter's conditions. Do not replace those checks with an automatic rule that all reconstitution is exempt.

The USP evidence used here is limited to scope questions 3–4 in its December 11, 2023 FAQ, checked November 3, 2026. The full current chapter was not verified for this guide. This supports a scope-reading exercise, not a numeric beyond-use-date chart, facility checklist, or complete compounding procedure. Confirm the current full standard before adding detailed procedural rules to your study notes.

A useful recall card pairs a rule with its conditions and source version. For broader recall practice alongside your own notes, 580 flashcards are planned for launch in full NAPLEX prep.

How do you separate quantity errors from other quality risks?

FDA identifies contamination and incorrect active-ingredient strength as possible consequences of poor compounding. These are distinct problems. Solving an amount calculation does not, by itself, establish that contamination has been controlled.

Try a fictional quality-review exercise: a practice stem says an ingredient calculation has been checked and is correct, but gives no information about contamination control. An answer claims that the correct calculation proves the preparation is free of contamination.

Reject the unsupported leap. The calculation answers a quantity question. It does not supply the missing quality evidence. Conversely, information about contamination control does not substitute for checking an ingredient calculation when the item asks about strength.

During review, finish this sentence: “My evidence establishes ___, but it does not establish ___.” That keeps an answer tied to the decision requested. For the arithmetic itself, work through the NAPLEX calculations examples and unit checks separately.

Use the 20 free NAPLEX practice questions for broader practice, then label your own errors by the reasoning step you missed. Do not assume a general practice set is a complete compounding assessment.

What should a compounding study checklist ask you to verify?

For each compounding exercise, record:

  • Decision: What exactly must I choose or calculate?
  • Preparation: What type is stated, and is hazardous handling also involved?
  • Issue: Is the problem quantity, contamination, product approval, or standard scope?
  • Source: Which official document addresses that issue, and which version am I using?
  • Conditions: What details must be true before the rule applies?
  • Reasoning: Why does my answer follow, and where does the tempting alternative overreach?

Choose your next study task from the missed step. An arithmetic error calls for quantity practice; an assumed exemption calls for reviewing scope and conditions. Put that task into the free NAPLEX study plan, then revisit a different exercise testing the same distinction.

For separate questions about official results and scoring, use the NAPLEX pass rates and passing-score guide. Keep your compounding checklist focused on what you can explain and verify.

When you are ready to combine focused review with a longer practice session, a 225-question mock exam is planned for launch in full NAPLEX prep. Carry the same habit into mixed questions: identify the decision first, then use evidence that actually answers it.

Trust the source

Official sources

Exam policies can change. Use these primary sources for the most current details.